IVA Stock — Price, Charts & Analysis

Inventiva S.A. (IVA) has no trailing P/E shown and a forward P/E of -5.58x. This places IVA in not enough valuation data territory based on the valuation data currently available on Worldtickers.

IVA trades with -5.58x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether IVA looks overvalued or undervalued.

IVA's P/E of -5.58x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

IVA's trailing EPS is -$2.20 and forward EPS is -$0.83.

EPS, or earnings per share, shows how much profit Inventiva S.A. generated for each share. IVA's trailing EPS is -$2.20, and investors usually prefer EPS that is positive and growing over time.

Inventiva S.A. has a market cap of $1.10B, making IVA a small-cap stock based on the current market value shown on Worldtickers.

IVA's latest stock price on Worldtickers is $4.65. The latest move is -$0.11 or -2.31%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

IVA's quote includes a latest price of $4.65. The market open is $4.74. Previous close is $4.76. The intraday range is $4.58 to $4.74.

IVA is down in the latest quote, with a move of -$0.11 or -2.31%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

IVA generated $6.76M in trailing revenue. Revenue growth is -89.90%, which helps show whether demand is expanding or slowing.

IVA's revenue growth is -89.90%, which is a negative demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

No, IVA does not show positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is -$354.14M.

Gross margin is 99.68%. Margins show how efficiently Inventiva S.A. turns revenue into profit.

Inventiva S.A. carries $230.89M and holds $99.84M in cash.

IVA holds $99.84M on its balance sheet.

IVA's book value per share is -$0.17.

Institutions hold 41.80% of IVA shares. Insiders hold 0.00% of shares. Ownership mix helps investors understand how much of Inventiva S.A. is held by professional investors and company insiders.

IVA has 236.22M shares outstanding. Float shares are 157.92M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for IVA, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for IVA is -$0.83. Revenue growth is -89.90%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

IVA's trailing EPS is -$2.20. Forward EPS is -$0.83. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

IVA is in the Healthcare sector. Its earnings multiple is -5.58x. Its latest displayed growth metric is -89.90%. Compare these figures with sector peers before deciding whether Inventiva S.A. is stronger or weaker than average.

IVA trades at $4.65. The stock trades at -5.58x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Inventiva S.A.'s fundamentals.

IVA risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 0.91, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

IVA should be compared with companies in Biotechnology. Its earnings multiple is -5.58x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Inventiva S.A. (IVA) operates in Healthcare, specifically Biotechnology. Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. The company also develops TGF-ß, a p

IVA trades on NasdaqGM. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

IVA stock is priced in USD on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Inventiva S.A.'s official website listed on Worldtickers is inventivapharma.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Inventiva S.A. employs about 69 people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

Inventiva S.A. is headquartered in Daix, France. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

IVA is in the Healthcare sector and the Biotechnology industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

IVA has traded between $3.35 and $7.98 over the past 52 weeks. At $4.65, it is 41.75% below the high and 38.81% above the low. The 52-week range helps gauge long-term price momentum.

IVA is between its 50-day and 200-day moving averages, which suggests a mixed trend setup. Its 50-day moving average is $4.25 and its 200-day moving average is $5.03.

IVA's RSI is 53.28. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

IVA's latest RSI reading is 53.28, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for IVA is near $4.22. Key resistance is near $4.94. Breaks above resistance or below support can change the short-term technical setup.

IVA's nearest reported support level is $4.22. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

IVA's nearest reported resistance level is $4.94. A breakout above resistance can improve momentum, especially when volume confirms the move.

IVA trades about 1.04M shares daily on average. The latest displayed volume is 517.34K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

IVA's MACD is -0.01, which is a negative momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

IVA is between its 50-day and 200-day moving averages, which suggests a mixed trend setup. RSI is 53.28 (neutral). MACD is bearish. Nearest support is around $4.22. Resistance is around $4.94. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is $4.62 (0.70% from price). MA50 is $4.25 (9.32% from price). MA200 is $5.03 (-7.55% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. IVA's MA20 is $4.62. MA50 is $4.25. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

IVA's pivot is near $4.75. Support is near $4.22. Resistance is near $4.94. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for IVA is near $4.27. The next upper resistance zone is near $4.91. These levels help define risk and possible follow-through zones after a breakout or breakdown.

IVA's Bollinger range is roughly $4.37 to $4.87. Band width is near 10.78%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

IVA's ATR-based typical daily range is about 4.59%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 517.34K shares. Average volume is about 1.04M shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

IVA's all-time high shown on Worldtickers is $19.06. Its all-time low is $1.53. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

IVA has a beta of 0.91, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.